TAVI with the ACURATE neo2 in severe bicuspid aortic valve stenosis: the Neo2 BAV Registry
Por:
Rück, A, Kim, WK, Del Sole, PA, Wagener, M, Mcinerney, A, Yacoub, MS, Hasabo, EA, Ayhan, C, Elzomor, H, Neiroukh, D, Amir, A, Saleh, N, Settergren, M, Lindler, R, Verouhis, D, Sossalla, S, Renker, M, Montorfano, M, Bellini, B, Suarez, XC, Del Olmo, VV, de Marco, F, Biroli, M, Moellmann, H, Enno, EC, Tarantini, G, Fabris, T, Ielasi, A, Costa, G, Barbanti, M, Soliman, O and Mylotte, D
Publicada:
1 ene 2025
Ahead of Print:
20 ene 2025
Resumen:
BACKGROUND: The ACURATE neo2 is a contemporary transcatheter aortic valve implantation (TAVI) system approved for the treatment of severe aortic stenosis in Europe. The ACURATE neo2 has not been evaluated in bicuspid aortic valve (BAV) stenosis. AIMS: We sought to evaluate the safety and efficacy of ACURATE neo2 in patients with BAV stenosis. METHODS: We retrospectively analysed consecutive severe BAV stenosis patients undergoing TAVI with ACURATE neo2 at 10 European centres. Imaging data from preprocedural multislice computed tomography, pre- and postprocedural echocardiography, and procedural cinefluoroscopy were evaluated by a core laboratory. Valve Academic Research Consortium 3 (VARC-3)-defined 30-day procedure safety and efficacy were the primary endpoints. Adverse events were site-reported according to VARC-3 criteria. RESULTS: Among 181 patients with BAV stenosis treated with the ACURATE neo2, the mean age was 77.5 +/- 7.2 years, 58.0% were female, and the Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) score was 2.3% (1.6-3.7%). Most procedures were transfemoral, and predilatation was performed in all cases. A second valve was required in 4 cases (2.2%). VARC-3-defined technical success was 95.6%. The primary endpoints of device success and early safety occurred in 90.6% and 82.3%, respectively. At 30 days, cardiovascular death occurred in 2.2% (N=4) and stroke in 1.6% (N=3). Core laboratory-adjudicated echocardiography reported an effective orifice area of 2.0 (1.7-2.5) cm2 and a mean transvalvular gradient of 6.5 (4.6-9.0) mmHg. Half of all cases (51.2%) had no paravalvular leak, while moderate leak occurred in 4.3%. A new permanent pacemaker was required in 11 patients (6.5%). CONCLUSIONS: The ACURATE neo2 demonstrated favourable clinical outcomes and bioprosthetic valve performance at 30 days in selected patients with severe BAV stenosis.
Filiaciones:
Rück, A:
Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden
Kim, WK:
Kerckhoff Heart Ctr, Dept Cardiol, Bad Nauheim, Germany
Justus Liebig Univ Giessen, Dept Cardiol, Giessen, Germany
Del Sole, PA:
Galway Univ Hosp, Newcastle Rd, Galway H91 YR71, Ireland
Wagener, M:
Galway Univ Hosp, Newcastle Rd, Galway H91 YR71, Ireland
Univ Hosp Basel, Univ Heart Ctr Basel, Basel, Switzerland
Mcinerney, A:
Galway Univ Hosp, Newcastle Rd, Galway H91 YR71, Ireland
Yacoub, MS:
Galway Univ Hosp, Newcastle Rd, Galway H91 YR71, Ireland
Univ Galway, Dept Med, Galway, Ireland
Hasabo, EA:
Galway Univ Hosp, Newcastle Rd, Galway H91 YR71, Ireland
Univ Galway, Dept Med, Galway, Ireland
Ayhan, C:
Galway Univ Hosp, Newcastle Rd, Galway H91 YR71, Ireland
Univ Galway, Dept Med, Galway, Ireland
Elzomor, H:
Galway Univ Hosp, Newcastle Rd, Galway H91 YR71, Ireland
Univ Galway, Dept Med, Galway, Ireland
Neiroukh, D:
Galway Univ Hosp, Newcastle Rd, Galway H91 YR71, Ireland
Univ Galway, Dept Med, Galway, Ireland
Sossalla, S:
Kerckhoff Heart Ctr, Dept Cardiol, Bad Nauheim, Germany
Justus Liebig Univ Giessen, Dept Cardiol, Giessen, Germany
Renker, M:
Kerckhoff Heart Ctr, Dept Cardiol, Bad Nauheim, Germany
Justus Liebig Univ Giessen, Dept Cardiol, Giessen, Germany
Montorfano, M:
Univ Vita Salute San Raffaele, Sch Med, Milan, Italy
IRCCS San Raffaele Sci Inst, Intervent Cardiol Unit, Milan, Italy
Bellini, B:
IRCCS San Raffaele Sci Inst, Intervent Cardiol Unit, Milan, Italy
Del Olmo, VV:
Hosp Univ Germans Trias I Pujol, Dept Gynecol & Obstet, Badalona, Spain
de Marco, F:
IRCCS, Milan, Italy
Biroli, M:
IRCCS, Milan, Italy
Moellmann, H:
St Johannes Hosp, D-44137 Dortmund, Germany
Enno, EC:
St Johannes Hosp, D-44137 Dortmund, Germany
Tarantini, G:
Univ Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Padua, Italy
Fabris, T:
Univ Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Padua, Italy
Ielasi, A:
IRCCS Osped Galeazzi St Ambrogio, Milan, Italy
Costa, G:
Univ Enna Kore, Umberto I Hosp, Enna, Italy
Barbanti, M:
DIEEI Univ Catania Italy, AOU Policlin G Rodolico San Marco, Catania, Italy
Soliman, O:
Galway Univ Hosp, Newcastle Rd, Galway H91 YR71, Ireland
Univ Galway, Dept Med, Galway, Ireland
Mylotte, D:
Galway Univ Hosp, Newcastle Rd, Galway H91 YR71, Ireland
Green Submitted
|